ArticleFrontiers in pediatrics2025
The global burden of childhood diarrhea and its epidemiological characteristics from 1990 to 2021.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Review
- Diagnostic and Microbiological Impact of Multiplex Syndromic Testing for Acute Infectious Gastroenteritis in a Regional Laboratory Network: A Real-World Before-After Study.Microorganisms · 2026Article
- Current status and future perspectives of fecal immunological markers in the differential diagnosis of Clostridioides difficile infection in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Review
- Effects of Bifidobacterium infantis M-63 on gut environment and bowel function during weaning: RCT.Pediatric research · 2026Article
- Prevalence of acute watery diarrhea in vulnerable children, mothers' knowledge, and management: a cross-sectional study from Yemen.Frontiers in pediatrics · 2026Article
- Estimating the global burden of diarrhea among young children with wasting and stunting and its projection to 2050: evidence from the Global Burden of Disease 2021 study.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diarrhea diseases remains a major contributor to global mortality and morbidity in children. This study aims to provide an updated assessment of rates in diarrhoea prevalence, incidence, mortality, and disability-adjusted life-years (DALYs) from 1990-2021, specifically focusing on including prevalence investigation alongside other measures. The analysis is stratified by sex, age, and socio-demographic index (SDI) at global, regional, and national levels. Methods: Data for this study was obtained from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Children aged 0-14 years with diarrhea were included in the analysis. The analyses were disaggregated by gender, 3 age categories, 21 GBD regions, 204 nations/territories, and 5 SDI quintiles. Incidence, all-cause mortality, cause-specific mortality, disability-adjusted life years (DALYs), and the corresponding estimated annual percent changes (EAPCs) were investigated. Results: In 2021, the global burden of diarrhea diseases remained substantial, with a total of 2,432,874,591 cases with an ASPR of 1,252.09 cases per 100,000 individuals (95% UI: 1,032.41-1,474.93). The ASIR was 83,866.84 per 100,000 people (95% UI: 66,140.64-101,854.13), while the ASDR was 18.6 per 100,000 persons (95% UI: 13.99-24.79). Additionally, the age-standardized DALY rate was 1,784.28 per 100,000 individuals (95%UI: 1,361.38-2,320.22). Regionally, areas with high-middle SDI exhibited the greatest ASPR, ASIR, ASDR, and age-standardized DALY rates, whereas high SDI regions had the lowest rates. The ASPR is mostly concentrated in children aged 10-14 years old, among which the ASPR of children under 5 years old has the most significant decline, from 3,138.81 per 100,000 people (95% UI: 2,749.19-3,557.51) in 1,990-885.07 per 100,000 people (95% UI: 755.93-1,029.39), a decrease of 71%. Geospatially, South Asia had the highest ASPR and the highest ASIR. The most pronounced increase was noted in the high-income Asia-Pacific region, which is the only area exhibiting growth, with an EAPC of 1.46 (95% CI: 1.11-1.82). Interestingly, between 1990 and 2021, the ASDR in Western Europe displayed the most pronounced rise, with an EAPC of 0.81, whereas the steepest decline was observed in East Asia. The greatest ASDR and age-standardized DALY rates were observed in the western region of sub-Saharan Africa, West Africa and Central Africa. Among countries, Madagascar had both the highest ASIR and ASDR. Furthermore, African countries exhibited the highest age-standardized DALY rate. Globally, unsafe water sources remained the primary risk factor for childhood diarrhea mortality and disability-adjusted life years (DALYs) from 1990-2021. While predominant in all Sociodemographic Index (SDI) regions except high-SDI areas, high-SDI regions reported non-exclusive breastfeeding and childhood wasting as leading mortality risk factors. Unsafe water sources are expected to persist as the principal contributor in the future. Discussion: The burden of childhood diarrhea diseases globally has been decreasing but remains a substantial contributor to DALYs. Low-middle SDI regions show persistently high age-standardized rates, with South Asia bearing the highest burden. Our study clarifies the global and regional epidemiology of childhood diarrheal diseases and identifies unsafe water sources as the predominant risk factor. These findings highlight the need for region-specific water safety initiatives in high-burden areas and are vital for shaping public health strategies and policy decisions for prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.